How a man with life-threatening peanut allergy now eats them every day | BBC News

Key Concepts:

• Peanut allergy desensitization
• Food immunotherapy
• Clinical trial
• Oral immunotherapy (OIT)
• Allergic reaction
• Desensitization process
• Medical supervision
• Quality of life improvement

Clinical Trial Overview:

A clinical trial conducted at King's College London and Guy's Hospital investigated whether adults with peanut allergies could be desensitized through oral immunotherapy (OIT). The study involved administering gradually increasing doses of peanut powder to participants, starting with minuscule amounts and progressing to whole peanuts.

Patient Experience (Chris):

Chris, a participant with a severe peanut allergy since childhood, described a near-fatal reaction he experienced ten years prior after consuming a curry. He detailed the rapid onset of symptoms, including tingling, spots, and intense pain, emphasizing the fear and anxiety associated with accidental exposure.

Desensitization Process:

1. Initial Dose: Participants began with an extremely small dose of peanut powder (8mg), mixed into their food.
2. Dose Escalation: Every two weeks, the dose was increased under medical supervision in a hospital setting.
3. Supervision: Participants were given supplies for two weeks to take home to mix with their meals daily. When they were going to go to the next dose, they came into hospital to have that tested with them under medical supervision.
4. Maintenance: By the end of the nine-month trial, successful participants could consume up to five peanuts without experiencing a reaction.
5. Ongoing Consumption: Participants must continue consuming peanuts daily to maintain desensitization.

Results and Outcomes:

• Two-thirds of the 21 patients in the trial were able to eat up to five peanuts without reacting by the end of the nine-month trial.
• The treatment is not a quick fix or a cure, requiring strict medical supervision and ongoing peanut consumption.

Food Immunotherapy Context:

Food immunotherapy is a relatively new treatment, primarily studied in children over the past 20 years. This research aims to extend treatment options to adults with peanut allergies.

Significance and Impact:

For Chris, the trial resulted in a significant improvement in his quality of life, alleviating the constant worry and fear associated with accidental peanut exposure. He expressed gratitude for the life-changing impact of the treatment.

Important Considerations:

• The desensitization process requires strict medical supervision and is not safe to attempt at home.
• The treatment is not a cure, and ongoing peanut consumption is necessary to maintain desensitization.

Quote:

• Chris: "I'm thankful, gratitude, um because it's it's really changed changed my life."

Conclusion:

The clinical trial demonstrates the potential of oral immunotherapy to desensitize adults with peanut allergies, significantly improving their quality of life. While not a cure, the treatment offers a way to manage the allergy and reduce the risk of severe reactions, provided it is administered under strict medical supervision and maintained with ongoing peanut consumption.